MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, DERM made $15,961K in revenue. -$2,230K in net income. Net profit margin of -13.97%.

Income Overview

Revenue
$15,961K
Net Income
-$2,230K
Net Profit Margin
-13.97%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Emrosi
    • Qbrexza
    • Accutane
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
15,961 16,079 17,631 15,009
Cost of goods sold - (excluding amortization of acquired intangible assets)
6,218 5,603* 5,755 4,939
Amortization of acquired intangible assets
1,126 1,065 1,064 1,064
Research and development
--9* 287 -
Selling, general and administrative
10,109 9,863 12,054 11,882
Total operating expenses
17,453 16,522 19,160 17,885
Loss from operations
-1,492 -443 -1,529 -2,876
Interest income
157 148 154 138
Interest expense
892 933 937 937
Foreign exchange transaction losses
-3 -19 -3 -61
Total other expense
-738 -804 -786 -860
Loss before income taxes
-2,230 -1,247 -2,315 -3,736
State
-15 --
Total current
-15* --
Federal
--556* --
State
--11* --
Total deferred
--567* --
Valuation allowance
-552* --
Income tax expense
-0 -60
Net loss
-2,230 -1,247 -2,315 -3,796
Basic EPS
-0.08 -0.046 -0.09 -0.16
Diluted EPS
-0.08 -0.046 -0.09 -0.16
Basic Average Shares
27,305,028 27,130,932 24,959,114 23,290,806
Diluted Average Shares
27,305,028 27,130,932 24,959,114 23,290,806
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,230K (45.25%↑ Y/Y)Emrosi$6,252K (202.03%↑ Y/Y)Qbrexza$5,028K (-2.58%↓ Y/Y)Accutane$3,314K (-9.33%↓ Y/Y)Foam FranchiseProducts Amzeeq Zilxi$1,050K Other Legacy$277K (-61.90%↓ Y/Y)Loss before incometaxes-$2,230K (45.25%↑ Y/Y)Product revenue, net$15,921K (21.17%↑ Y/Y)Other revenue$40K Loss from operations-$1,492K (55.11%↑ Y/Y)Total other expense-$738K (1.47%↑ Y/Y)Total revenue$15,961K (21.48%↑ Y/Y)Interest income$157K (5.37%↑ Y/Y)Total operatingexpenses$17,453K (6.01%↑ Y/Y)Interest expense$892K (0.11%↑ Y/Y)Foreign exchangetransaction losses-$3K (57.14%↑ Y/Y)Selling, general andadministrative$10,109K (-4.35%↓ Y/Y)Cost of goods sold -(excluding amortization of...$6,218K (29.81%↑ Y/Y)Amortization of acquiredintangible assets$1,126K (5.73%↑ Y/Y)

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)